Literature DB >> 18508791

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.

Li Wang1, Carrie Fidler, Nandita Nadig, Aristoteles Giagounidis, Matteo G Della Porta, Luca Malcovati, Sally Killick, Norbert Gattermann, Carlo Aul, Jacqueline Boultwood, James S Wainscoat.   

Abstract

BACKGROUND: We undertook a genome wide single nucleotide polymorphism analysis of a spectrum of patients with myelodysplastic syndrome del(5q) in order to investigate whether additional genomic abnormalities occur. Single nucleotide polymorphism array analysis has been shown to detect not only gene deletions but also regions of uniparental disomy that can pinpoint particular regions for mutation analysis. DESIGN AND METHODS: We studied 42 cases of myelodysplastic syndrome with del(5q), comprising 21 patients with 5q- syndrome and 21 with del(5q) (not 5q- syndrome), and 45 healthy controls by genome wide single nucleotide polymorphism analysis with the 50K Affymetrix single nucleotide polymorphism arrays.
RESULTS: The del(5q) was characterized in all cases. The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb. Copy number changes in addition to the del(5q) were observed in 10 of 21 patients with del(5q) myelodysplastic syndrome but in none of the patients with the 5q- syndrome. A total of 63 regions of uniparental disomy greater than 2 Mb were detected in 40 of 42 patients, dispersed on 18/23 chromosomes. In the 5q- syndrome group 31 regions of uniparental disomy were identified in 19 of 21 patients, the largest one being 7.6 Mb. All 21 patients with del(5q) myelodysplastic syndrome had uniparental disomy; in total 32 regions of uniparental disomy were identified in the 21 patients, including six regions of uniparental disomy > 10 Mb. Eight recurrent regions of uniparental disomy were observed among the 42 patients. For eight patients we had T-cell DNA as a germline control and four recurrent regions of uniparental disomy were identified that were present only in the neutrophil and not T-cell DNA. One small region of uniparental disomy at 10p12.31-p12.2 was observed in four patients with the 5q- syndrome.
CONCLUSIONS: This study shows that regions of uniparental disomy greater than 2 Mb are found in the 5q-syndrome and del(5q) myelodysplastic syndrome, although large regions of uniparental disomy (>10 Mb) are only found in the latter group. The recurrent regions of uniparental disomy may indicate the position of novel leukemia-associated genes.

Entities:  

Mesh:

Year:  2008        PMID: 18508791     DOI: 10.3324/haematol.12603

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  13 in total

1.  Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q.

Authors:  M Heuser; M Meggendorfer; M M A Cruz; J Fabisch; S Klesse; L Köhler; G Göhring; C Ganster; K Shirneshan; A Gutermuth; S Cerny-Reiterer; J Krönke; V Panagiota; C Haferlach; C Koenecke; U Platzbecker; C Thiede; T Schroeder; G Kobbe; S Ehrlich; K Stamer; K Döhner; P Valent; B Schlegelberger; N Kroeger; A Ganser; D Haase; T Haferlach; F Thol
Journal:  Leukemia       Date:  2015-02-24       Impact factor: 11.528

2.  Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.

Authors:  Andres Jerez; Lukasz P Gondek; Anna M Jankowska; Hideki Makishima; Bartlomiej Przychodzen; Ramon V Tiu; Christine L O'Keefe; Azim M Mohamedali; Denise Batista; Mikkael A Sekeres; Michael A McDevitt; Ghulam J Mufti; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

3.  Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.

Authors:  Marta Fernandez-Mercado; Adam Burns; Andrea Pellagatti; Aristoteles Giagounidis; Ulrich Germing; Xabier Agirre; Felipe Prosper; Carlo Aul; Sally Killick; James S Wainscoat; Anna Schuh; Jacqueline Boultwood
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

4.  Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

Authors:  Daniel T Starczynowski; Florian Kuchenbauer; Bob Argiropoulos; Sandy Sung; Ryan Morin; Andrew Muranyi; Martin Hirst; Donna Hogge; Marco Marra; Richard A Wells; Rena Buckstein; Wan Lam; R Keith Humphries; Aly Karsan
Journal:  Nat Med       Date:  2009-11-08       Impact factor: 53.440

5.  Acquired mutations in TET2 are common in myelodysplastic syndromes.

Authors:  Saskia M C Langemeijer; Roland P Kuiper; Marieke Berends; Ruth Knops; Mariam G Aslanyan; Marion Massop; Ellen Stevens-Linders; Patricia van Hoogen; Ad Geurts van Kessel; Reinier A P Raymakers; Eveline J Kamping; Gregor E Verhoef; Estelle Verburgh; Anne Hagemeijer; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

6.  Autogenous Control of 5′TOP mRNA Stability by 40S Ribosomes.

Authors:  Antonio Gentilella; Francisco D Morón-Duran; Pedro Fuentes; Guilherme Zweig-Rocha; Ferran Riaño-Canalias; Joffrey Pelletier; Marta Ruiz; Gemma Turón; Julio Castaño; Albert Tauler; Clara Bueno; Pablo Menéndez; Sara C Kozma; George Thomas
Journal:  Mol Cell       Date:  2017-06-29       Impact factor: 17.970

7.  Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes.

Authors:  Marilyn L Slovak; David D Smith; Victoria Bedell; Ya-Hsuan Hsu; Margaret O'Donnell; Stephen J Forman; Karl Gaal; Lisa McDaniel; Roger Schultz; Blake C Ballif; Lisa G Shaffer
Journal:  Mol Cytogenet       Date:  2010-11-15       Impact factor: 2.009

Review 8.  Ribosomopathies: mechanisms of disease.

Authors:  Hani Nakhoul; Jiangwei Ke; Xiang Zhou; Wenjuan Liao; Shelya X Zeng; Hua Lu
Journal:  Clin Med Insights Blood Disord       Date:  2014-08-14

9.  SPARC silencing inhibits the growth of acute myeloid leukemia transformed from myelodysplastic syndrome via induction of cell cycle arrest and apoptosis.

Authors:  Qing Nian; Qing Xiao; Li Wang; Jing Luo; Li-Ping Chen; Ze-Song Yang; Lin Liu
Journal:  Int J Mol Med       Date:  2014-02-07       Impact factor: 4.101

10.  RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.

Authors:  Heba A Alkhatabi; Donal P McLornan; Austin G Kulasekararaj; Farooq Malik; Thomas Seidl; David Darling; Joop Gaken; Ghulam J Mufti
Journal:  Oncotarget       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.